Mesa Laboratories, Inc. is focused primarily on quality control products and services. The Company operates through four segments: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. The Instruments Division designs, manufactures and markets quality control instruments and disposable products. Its Biological Indicators Division provides testing services, along with the manufacturing and marketing of biological indicators and distribution of chemical indicators used to assess the effectiveness of sterilization processes. Its Continuous Monitoring Division designs, develops and markets systems, which are used to monitor various environmental parameters. Its Cold Chain Division provides parameter (primarily temperature) monitoring of products in a cold chain. The Company's brands include DataTrace, DialyGuard, DryCal, Torqo, SureTorque, BGI, Mesa, PCD, Apex, CheckPoint, Mesa and TempTrust.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Testing & Measuring Equipment
- Sub-Industry: Electronic Equipment & Instruments
- Symbol: NASDAQ:MLAB
- CUSIP: 59064R10
- Web: www.mesalabs.com
Capitalization:- Market Cap: $488.59 million
- Outstanding Shares: 3,759,000
Average Prices:- 50 Day Moving Avg: $142.50
- 200 Day Moving Avg: $136.41
- 52 Week Range: $102.62 - $169.80
P/E:- Trailing P/E Ratio: 46.72
- Foreward P/E Ratio: 38.34
- P/E Growth: 0.00
Sales & Book Value:- Annual Revenue: $95.22 million
- Price / Sales: 5.13
- Book Value: $26.87 per share
- Price / Book: 4.84
Dividend:- Annual Dividend: $0.64
- Dividend Yield: 0.5%
Profitability:- EBIDTA: $25.86 million
- Net Margins: 11.31%
- Return on Equity: 16.58%
- Return on Assets: 9.37%
Debt:- Debt-to-Equity Ratio: 0.49%
- Current Ratio: 2.26%
- Quick Ratio: 1.37%
Misc:- Average Volume: 19,908 shs.
- Beta: 0.46
- Short Ratio: 12.97
Frequently Asked Questions for Mesa Laboratories (NASDAQ:MLAB)
What is Mesa Laboratories' stock symbol?
Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."
How often does Mesa Laboratories pay dividends? What is the dividend yield for Mesa Laboratories?
Mesa Laboratories declared a quarterly dividend on Thursday, July 6th. Shareholders of record on Thursday, August 31st will be given a dividend of $0.16 per share on Friday, September 15th. This represents a $0.64 dividend on an annualized basis and a yield of 0.49%. The ex-dividend date of this dividend is Tuesday, August 29th. View Mesa Laboratories' Dividend History.
How were Mesa Laboratories' earnings last quarter?
Mesa Laboratories, Inc. (NASDAQ:MLAB) released its quarterly earnings data on Monday, July, 31st. The company reported $0.39 earnings per share for the quarter, missing the consensus estimate of $0.56 by $0.17. The company earned $22.67 million during the quarter, compared to analysts' expectations of $22.90 million. Mesa Laboratories had a net margin of 11.31% and a return on equity of 16.58%. View Mesa Laboratories' Earnings History.
Who are some of Mesa Laboratories' key competitors?
Some companies that are related to Mesa Laboratories include Cardiovascular Systems (CSII), Aimmune Therapeutics (AIMT), Dermira (DERM), China Cord Blood Corporation (CO), AKCEA THERAPEUT (AKCA), Albany Molecular Research (AMRI), Immunomedics (IMMU), Xencor (XNCR), Retrophin (RTRX), Ascendis Pharma A/S (ASND), Pharmerica Corporation (PMC), Mazor Robotics (MZOR), BeyondSpring (BYSI), Dynavax Technologies Corporation (DVAX), Intersect ENT (XENT), Orthofix International N.V. (OFIX), Luminex Corporation (LMNX) and Sangamo Therapeutics (SGMO).
Who are Mesa Laboratories' key executives?
Mesa Laboratories' management team includes the folowing people:
- H. Stuart Campbell, Chairman of the Board
- John J. Sullivan Ph.D., President, Chief Executive Officer, Treasurer, Director
- John V. Sakys, Chief Financial Officer, Executive Vice President, Chief Accounting Officer, Corporate Secretary
- Gary Owens, Chief Operating Officer, Vice President
- Glenn E. Adriance, Chief Sales and Marketing Officer
- Robert V. Dwyer, Director
- John Bradley Schmieder, Director
- Michael T. Brooks, Independent Director
- Evan C. Guillemin, Independent Director
- David M. Kelly, Independent Director
Who owns Mesa Laboratories stock?
Mesa Laboratories' stock is owned by many different of retail and institutional investors. Top institutional investors include Conestoga Capital Advisors LLC (9.44%), FMR LLC (7.57%), Vanguard Group Inc. (3.86%), Victory Capital Management Inc. (3.51%), Dimensional Fund Advisors LP (3.44%) and Renaissance Technologies LLC (2.32%). Company insiders that own Mesa Laboratories stock include David M Kelly, Glenn E Adriance, H Stuart Campbell, John James Sullivan, John Sakys, Michael T Brooks and Robert V Dwyer. View Institutional Ownership Trends for Mesa Laboratories.
Who sold Mesa Laboratories stock? Who is selling Mesa Laboratories stock?
Mesa Laboratories' stock was sold by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC, Punch & Associates Investment Management Inc., Crawford Investment Counsel Inc., Ameriprise Financial Inc., Rice Hall James & Associates LLC, FMR LLC, Bahl & Gaynor Inc. and Victory Capital Management Inc.. Company insiders that have sold Mesa Laboratories stock in the last year include David M Kelly, Glenn E Adriance, H Stuart Campbell, John James Sullivan, John Sakys, Michael T Brooks and Robert V Dwyer. View Insider Buying and Selling for Mesa Laboratories.
Who bought Mesa Laboratories stock? Who is buying Mesa Laboratories stock?
Mesa Laboratories' stock was bought by a variety of institutional investors in the last quarter, including Pembroke Management LTD, Thomson Horstmann & Bryant Inc., Royce & Associates LP, Vanguard Group Inc., Martingale Asset Management L P, Renaissance Technologies LLC, King Luther Capital Management Corp and Dimensional Fund Advisors LP. View Insider Buying and Selling for Mesa Laboratories.
How do I buy Mesa Laboratories stock?
Shares of Mesa Laboratories can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Mesa Laboratories' stock price today?
One share of Mesa Laboratories stock can currently be purchased for approximately $129.98.
MarketBeat Community Rating for Mesa Laboratories (NASDAQ MLAB)MarketBeat's community ratings are surveys of what our community members think about Mesa Laboratories and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Mesa Laboratories (NASDAQ:MLAB) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 1 Buy Rating |
| Consensus Rating: | Buy (Score: 3.00) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for Mesa Laboratories (NASDAQ:MLAB)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 12/23/2016 | Janney Montgomery Scott | Reiterated Rating | Buy | | N/A |  |
| 6/10/2016 | Sidoti | Downgrade | Buy -> Neutral | $132.00 | N/A | |
(Data available from 8/20/2015 forward)
Earnings History for Mesa Laboratories (NASDAQ:MLAB)Earnings History by Quarter for Mesa Laboratories (NASDAQ MLAB)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 7/31/2017 | Q1 2018 | $0.56 | $0.39 | $22.90 million | $22.67 million | View | N/A | |
| 6/7/2017 | Q4 2017 | $1.00 | $1.24 | $27.10 million | $24.30 million | View | N/A | |
| 2/2/2017 | Q3 2017 | $0.62 | $1.19 | $22.60 million | $23.84 million | View | N/A | |
| 11/2/2016 | Q217 | $0.85 | $0.92 | $23.80 million | $24.40 million | View | N/A | |
| 7/28/2016 | Q1 | $0.89 | $0.89 | $21.20 million | $21.11 million | View | N/A | |
| 6/2/2016 | Q4 | $0.94 | $1.33 | $21.00 million | $24.81 million | View | N/A | |
| 8/3/2015 | Q116 | $0.83 | $0.85 | $18.78 billion | $18.20 billion | View | N/A | |
| 6/1/2015 | Q415 | $0.91 | $0.80 | | $18.56 million | View | N/A | |
| 2/2/2015 | Q315 | $0.73 | $0.87 | | $17.83 million | View | N/A | |
| 11/3/2014 | Q215 | $0.69 | $0.84 | $12.68 million | $18.54 million | View | N/A | |
| 8/6/2014 | Q115 | $0.67 | $0.71 | $11.22 million | $16.40 million | View | N/A | |
| 6/2/2014 | Q414 | $0.70 | $1.15 | $12.80 million | $15.70 million | View | N/A | |
| 2/3/2014 | Q4 | | $0.62 | | | View | N/A | |
| 5/29/2013 | Q113 | $0.59 | $0.76 | $13.13 million | $12.81 million | View | N/A | |
| 2/5/2013 | Q3 2013 | $0.67 | $0.56 | $11.76 million | $11.36 million | View | N/A | |
| 11/8/2012 | Q312 | $0.61 | $0.76 | $11.48 million | $11.71 million | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Mesa Laboratories (NASDAQ:MLAB)Current Year EPS Consensus Estimate: $2.72 EPS
Next Year EPS Consensus Estimate: $3.39 EPS
Current Dividend Information for Mesa Laboratories (NASDAQ:MLAB)| Next Dividend: | 9/15/2017 |
| Annual Dividend: | $0.64 |
| Dividend Yield: | 0.49% |
| Dividend Growth: | 3.90% (3 Year Average) |
| Payout Ratio: | 22.94% (Trailing 12 Months of Earnings)
23.53% (Based on This Year's Estimates)
18.88% (Based on Next Year's Estimates)
|
Dividend History by Quarter for Mesa Laboratories (NASDAQ MLAB)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 7/6/2017 | quarterly | $0.16 | 0.45% | 8/29/2017 | 8/31/2017 | 9/15/2017 |
| 4/6/2017 | quarterly | $0.16 | 0.5% | 5/26/2017 | 5/31/2017 | 6/15/2017 |
| 1/4/2017 | quarterly | $0.16 | 0.51% | 2/24/2017 | 2/28/2017 | 3/15/2017 |
| 10/5/2016 | quarterly | $0.16 | 0.54% | 11/28/2016 | 11/30/2016 | 12/15/2016 |
| 7/7/2016 | quarterly | $0.16 | 0.52% | 8/29/2016 | 8/31/2016 | 9/15/2016 |
| 4/13/2016 | quarterly | $0.16 | 0.64% | 5/26/2016 | 5/31/2016 | 6/15/2016 |
| 1/6/2016 | quarterly | $0.16 | 0.71% | 2/25/2016 | 2/29/2016 | 3/15/2016 |
| 10/5/2015 | quarterly | $0.16 | 0.57% | 11/25/2015 | 11/30/2015 | 12/15/2015 |
| 7/9/2015 | quarterly | $0.16 | 0.72% | 8/27/2015 | 8/31/2015 | 9/15/2015 |
| 4/3/2015 | quarterly | $0.16 | 0.93% | 5/27/2015 | 5/29/2015 | 6/15/2015 |
| 1/7/2015 | quarterly | $0.16 | 0.84% | 2/25/2015 | 2/27/2015 | 3/16/2015 |
| 10/14/2014 | quarterly | $0.16 | 0.95% | 11/25/2014 | 11/28/2014 | 12/15/2014 |
| 7/17/2014 | quarterly | $0.15 | 0.73% | 8/27/2014 | 8/29/2014 | 9/15/2014 |
| 4/23/2014 | quarterly | $0.15 | 0.69% | 5/28/2014 | 5/30/2014 | 6/16/2014 |
| 1/31/2014 | quarterly | $0.15 | 0.75% | 2/26/2014 | 2/28/2014 | 3/17/2014 |
| 11/1/2013 | quarterly | $0.15 | 0.88% | 11/26/2013 | 11/29/2013 | 12/16/2013 |
| 8/7/2013 | quarterly | $0.14 | 0.92% | 8/28/2013 | 8/30/2013 | 9/18/2013 |
| 4/18/2013 | quarterly | $0.14 | 1.1% | 5/22/2013 | 5/27/2013 | 6/24/2013 |
| 4/17/2013 | quarterly | $0.14 | | | 5/27/2013 | 6/14/2013 |
| 2/6/2013 | quarterly | $0.14 | 1.08% | 2/25/2013 | 2/27/2013 | 3/15/2013 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for Mesa Laboratories (NASDAQ:MLAB)Insider Ownership Percentage: 17.00%
Institutional Ownership Percentage: 67.11%
Insider Trades by Quarter for Mesa Laboratories (NASDAQ:MLAB)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 8/15/2017 | H Stuart Campbell | Director | Sell | 2 | $134.10 | $268.20 | |
| 8/11/2017 | H Stuart Campbell | Director | Sell | 608 | $134.08 | $81,520.64 | |
| 8/10/2017 | H Stuart Campbell | Director | Sell | 1,000 | $136.58 | $136,580.00 | |
| 8/9/2017 | H Stuart Campbell | Director | Sell | 1,000 | $137.61 | $137,610.00 | |
| 8/4/2017 | H Stuart Campbell | Director | Sell | 1,000 | $143.09 | $143,090.00 | |
| 8/3/2017 | H Stuart Campbell | Director | Sell | 2,000 | $143.37 | $286,740.00 | |
| 6/16/2017 | Robert V Dwyer | Director | Sell | 11,150 | $139.46 | $1,554,979.00 | |
| 6/12/2017 | David M Kelly | Director | Sell | 1,000 | $142.00 | $142,000.00 | |
| 6/9/2017 | Glenn E Adriance | Insider | Sell | 4,000 | $148.98 | $595,920.00 | |
| 3/20/2017 | Michael T Brooks | Director | Sell | 2,000 | $122.94 | $245,880.00 | |
| 2/22/2017 | Robert V Dwyer | Director | Sell | 5,000 | $125.13 | $625,650.00 | |
| 2/21/2017 | John James Sullivan | Insider | Sell | 9,078 | $124.83 | $1,133,206.74 | |
| 2/13/2017 | John James Sullivan | CEO | Sell | 5,922 | $123.99 | $734,268.78 | |
| 2/7/2017 | Glenn E Adriance | Insider | Sell | 8,070 | $124.15 | $1,001,890.50 | |
| 2/7/2017 | H Stuart Campbell | Director | Sell | 8,000 | $121.55 | $972,400.00 | |
| 11/23/2016 | Glenn E Adriance | Insider | Sell | 3,567 | $135.93 | $484,862.31 | |
| 11/17/2016 | John Sakys | CFO | Sell | 1,000 | $127.14 | $127,140.00 | |
| 10/21/2016 | H Stuart Campbell | Director | Sell | 4,000 | $119.02 | $476,080.00 | |
| 9/16/2016 | H Stuart Campbell | Director | Sell | 3,000 | $115.03 | $345,090.00 | |
| 6/22/2016 | John James Sullivan | CEO | Sell | 4,000 | $121.63 | $486,520.00 | |
| 6/6/2016 | Glenn E Adriance | Insider | Sell | 3,000 | $111.74 | $335,220.00 | |
| 3/11/2016 | H Stuart Campbell | Director | Sell | 6,000 | $86.32 | $517,920.00 | |
| 3/7/2016 | H Stuart Campbell | Director | Sell | 280 | $90.00 | $25,200.00 | |
| 2/24/2016 | H Stuart Campbell | Director | Sell | 1,532 | $92.90 | $142,322.80 | |
| 11/6/2015 | John James Sullivan | CEO | Sell | 2,400 | $112.99 | $271,176.00 | |
| 9/22/2015 | H Stuart Campbell | Director | Buy | 150 | $109.54 | $16,431.00 | |
| 9/17/2015 | Robert V Dwyer | Director | Sell | 2,000 | $113.00 | $226,000.00 | |
| 9/15/2015 | Robert V Dwyer | Director | Sell | 3,000 | $111.67 | $335,010.00 | |
| 9/11/2015 | Robert V Dwyer | Director | Sell | 1,000 | $110.00 | $110,000.00 | |
| 9/8/2015 | Robert V Dwyer | Director | Sell | 1,000 | $110.39 | $110,390.00 | |
| 8/17/2015 | Robert V Dwyer | Director | Sell | 1,937 | $116.50 | $225,660.50 | |
| 3/14/2014 | Luke R Schmieder | Director | Sell | 5,000 | $90.04 | $450,200.00 | |
| 2/27/2014 | Glenn E Adriance | Insider | Sell | 1,000 | $87.68 | $87,680.00 | |
| 2/25/2014 | John James Sullivan | CEO | Sell | 10,000 | $87.01 | $870,100.00 | |
| 12/9/2013 | Glenn E Adriance | Insider | Sell | 4,825 | $73.68 | $355,506.00 | |
| 11/15/2013 | Robert V Dwyer | Director | Sell | 13,476 | $71.33 | $961,243.08 | |
| 11/14/2013 | Robert V Dwyer | Director | Sell | 6,524 | $71.33 | $465,356.92 | |
| 8/19/2013 | John James Sullivan | CEO | Sell | 6,000 | $64.87 | $389,220.00 | |
| 8/14/2013 | John James Sullivan | CEO | Sell | 6,000 | $61.92 | $371,520.00 | |
| 3/5/2013 | H Stuart Campbell | Director | Sell | 30,000 | $52.75 | $1,582,500.00 | |
| 12/27/2012 | Steven W Peterson | CFO | Sell | 17,054 | $48.50 | $827,119.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Mesa Laboratories (NASDAQ:MLAB)
Latest Headlines for Mesa Laboratories (NASDAQ:MLAB)
| Source: |
|
| Date | Headline |
|---|
 | H Stuart Campbell Sells 608 Shares of Mesa Laboratories, Inc. (MLAB) Stock
www.americanbankingnews.com - August 15 at 1:40 PM |
| Mesa Laboratories, Inc. (NASDAQ:MLAB) Receives Consensus Recommendation of "Strong Buy" from Analysts
www.americanbankingnews.com - August 14 at 10:08 PM |
| Critical Analysis: Mesa Laboratories (MLAB) vs. ESCO Technologies (ESE)
www.americanbankingnews.com - August 13 at 4:16 AM |
| Mesa Laboratories, Inc. (MLAB) Downgraded by BidaskClub
www.americanbankingnews.com - August 12 at 11:20 AM |
| Mesa Laboratories, Inc. (MLAB) Director H Stuart Campbell Sells 1,000 Shares
www.americanbankingnews.com - August 11 at 1:22 PM |
| Insider Selling: Mesa Laboratories, Inc. (MLAB) Director Sells 1,000 Shares of Stock
www.americanbankingnews.com - August 11 at 1:18 PM |
 | Mesa Laboratories, Inc. – Value Analysis (NASDAQ:MLAB) : August 7, 2017
finance.yahoo.com - August 7 at 8:02 PM |
| Mesa Laboratories, Inc. (NASDAQ:MLAB) Director H Stuart Campbell Sells 2,000 Shares
www.americanbankingnews.com - August 4 at 1:24 PM |
| Mesa Laboratories, Inc. (NASDAQ:MLAB) Releases Earnings Results, Misses Expectations By $0.17 EPS
www.americanbankingnews.com - August 1 at 11:56 AM |
| Badger Meter (BMI) versus Mesa Laboratories (MLAB) Head to Head Analysis
www.americanbankingnews.com - July 31 at 10:24 PM |
 | Mesa Labs Reports Record First Quarter Revenues
www.nasdaq.com - July 31 at 8:17 PM |
| Mesa Labs posts 1Q profit
finance.yahoo.com - July 31 at 8:17 PM |
| Mesa Laboratories, Inc. breached its 50 day moving average in a Bearish Manner : MLAB-US : July 26, 2017
finance.yahoo.com - July 28 at 4:16 PM |
| QIAGEN (QGEN) Beats on Earnings & Sales in Q2, Raises View
finance.yahoo.com - July 28 at 4:16 PM |
| Align Technology (ALGN) Beats on Q2 Earnings and Revenues
finance.yahoo.com - July 28 at 4:16 PM |
| GNC Holdings (GNC) Tops Q2 Earnings, Misses Sales Estimates
finance.yahoo.com - July 28 at 4:16 PM |
 | Signal Bay, Inc. Parent Company of EVIO Labs provides Corporate Update
globenewswire.com - July 21 at 4:31 PM |
| Mesa Laboratories, Inc. (NASDAQ:MLAB) Given Consensus Rating of "Strong Buy" by Brokerages
www.americanbankingnews.com - July 20 at 12:41 PM |
| Analyzing Mesa Laboratories (MLAB) & EXFO (EXFO)
www.americanbankingnews.com - July 17 at 10:32 PM |
 | Here's Why Investors Should Invest in Bruker (BRKR) Now
www.zacks.com - July 17 at 3:21 PM |
| BioTelemetry (BEAT) Acquires LifeWatch for $280 Million
finance.yahoo.com - July 17 at 10:24 AM |
| Mesa Laboratories, Inc. breached its 50 day moving average in a Bullish Manner : MLAB-US : July 12, 2017
finance.yahoo.com - July 13 at 6:51 AM |
| Mesa Laboratories, Inc. (MLAB) to Issue $0.16 Quarterly Dividend
www.americanbankingnews.com - July 6 at 5:00 PM |
| Mesa Laboratories, Inc. (MLAB) Receives Average Rating of "Strong Buy" from Brokerages
www.americanbankingnews.com - July 3 at 10:59 AM |
| ETFs with exposure to Mesa Laboratories, Inc. : June 22, 2017
finance.yahoo.com - June 23 at 8:04 AM |
| Earnings Highlights and Review: Cooper's Quarterly Revenue Grew 8%; Non-GAAP Earnings Jumped 22%
finance.yahoo.com - June 22 at 8:36 AM |
| Zacks: Mesa Laboratories, Inc. (MLAB) Given Consensus Recommendation of "Strong Buy" by Brokerages
www.americanbankingnews.com - June 16 at 10:46 PM |
| Mesa Laboratories, Inc. :MLAB-US: Earnings Analysis: Q4, 2017 By the Numbers : June 16, 2017
finance.yahoo.com - June 16 at 7:32 PM |
| Robert V. Dwyer Sells 11,150 Shares of Mesa Laboratories, Inc. (MLAB) Stock
www.americanbankingnews.com - June 16 at 7:14 PM |
| Mesa Laboratories, Inc. (MLAB) Upgraded to Buy by Zacks Investment Research
www.americanbankingnews.com - June 13 at 5:18 PM |
| Mesa Laboratories, Inc. (MLAB) Insider Glenn E. Adriance Sells 4,000 Shares
www.americanbankingnews.com - June 12 at 7:14 PM |
| Mesa Laboratories, Inc. breached its 50 day moving average in a Bearish Manner : MLAB-US : June 12, 2017
finance.yahoo.com - June 12 at 3:56 PM |
| ETFs with exposure to Mesa Laboratories, Inc. : June 12, 2017
finance.yahoo.com - June 12 at 3:56 PM |
| Mesa Laboratories, Inc. (MLAB) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - June 10 at 7:26 AM |
| Mesa Laboratories, Inc. :MLAB-US: Earnings Analysis: 2017 By the Numbers : June 9, 2017
finance.yahoo.com - June 9 at 6:46 PM |
| Mesa Laboratories, Inc. (MLAB) Releases Earnings Results, Misses Expectations By $0.06 EPS
www.americanbankingnews.com - June 8 at 8:14 AM |
| Mesa Labs Reports Record Net Income and Adjusted Net Income
finance.yahoo.com - June 7 at 9:07 AM |
| Mesa Labs posts 4Q profit
finance.yahoo.com - June 7 at 9:07 AM |
| Can The Uptrend Continue for Mesa Laboratories (MLAB)?
finance.yahoo.com - June 6 at 9:26 AM |
| Mesa Laboratories, Inc. : MLAB-US: Dividend Analysis : May 31st, 2017 (record date) : By the numbers : May 29, 2017
finance.yahoo.com - May 29 at 6:03 PM |
| Mesa Laboratories, Inc. (MLAB) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - May 27 at 10:04 PM |
| Mesa Laboratories (MLAB) Earning Positive Media Coverage, Analysis Finds
www.americanbankingnews.com - May 8 at 11:44 PM |
| Mesa Laboratories (MLAB) Earns Media Sentiment Score of -0.14
www.americanbankingnews.com - May 3 at 9:28 AM |
| Mesa Laboratories (MLAB) Receives Media Impact Rating of 0.31
www.americanbankingnews.com - April 29 at 12:54 AM |
| Mesa Laboratories, Inc. (MLAB) Downgraded to Hold at Zacks Investment Research
www.americanbankingnews.com - April 14 at 12:54 PM |
| Mesa Laboratories (MLAB) Receiving Negative Media Coverage, Study Finds
www.americanbankingnews.com - April 13 at 10:40 AM |
| Mesa Laboratories, Inc. Plans Quarterly Dividend of $0.16 (MLAB)
www.americanbankingnews.com - April 6 at 6:15 PM |
| Mesa Laboratories, Inc. (MLAB) Director Sells $245,880.00 in Stock
www.americanbankingnews.com - March 21 at 1:25 PM |
| MESA LABORATORIES INC /CO Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - March 20 at 4:45 PM |
| MESA LABORATORIES INC /CO Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material D
biz.yahoo.com - March 2 at 9:31 AM |
Mesa Laboratories (MLAB) Chart for Sunday, August, 20, 2017
